Scales (NZSE:SCL) Research & Development: NZ$0.0 Mil (TTM As of Dec. 2025)


NZSE:SCL Scales Corp Ltd NZSE:SCL
99 GF Score
Price NZ$6.22
GF Value NZ$6.68
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Scales Research & Development?

Scales NZSE:SCL +1.14% 99 Research & Development is NZ$0.0 Mil as of Dec. 2025. GuruFocus rates NZSE:SCL with a GF Score™ of 99/100 and a GF Value™ of NZ$6.68 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Scales's Research & Development for the six months ended in Dec. 2025 was NZ$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NZ$0.0 Mil.

Scales  (NZSE:SCL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Scales Research & Development Related Terms

Scales Research & Development Historical Data

* Premium members only.

The historical data trend for Scales's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scales Research & Development Chart

Scales Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Scales Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NZSE:SCL
99GF Score
Scales Corp Ltd NZSE:SCL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scales Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NZ$0.0 Mil mean?
Scales (NZSE:SCL) has a Research & Development of NZ$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Scales and its competitors.
Is Scales' Research & Development too high?
Scales' current Research & Development is NZ$0.0 Mil. Overall, Scales has a GF Score™ of 99/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scales' Research & Development compare to KHC and GIS?
Scales' Research & Development of NZ$0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Scales and its competitors. Scales's current Research & Development is NZ$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scales stock overvalued right now?
Based on GuruFocus' analysis, Scales (NZSE:SCL) is currently considered Fairly Valued. The stock's GF Value™ is NZ$6.68, compared to a current price of NZ$6.22 — trading 6.9% below its estimated fair value. The current Research & Development is NZ$0.0 Mil. Scales' overall GF Score™ is 99/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Scales (NZSE:SCL), the current Research & Development is NZ$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scales (NZSE:SCL) Overvalued in 2026?

Based on GuruFocus' analysis, Scales stock appears to be undervalued. The current stock price of NZ$6.22 is trading 6.9% below its estimated GF Value™ of NZ$6.68. GuruFocus considers Scales to be Fairly Valued.

Key valuation signals for NZSE:SCL:

  • Research & Development: NZ$0.0 Mil
  • GF Value™: NZ$6.68 vs. price of NZ$6.22 (6.9% below fair value)
  • GF Score™: 99/100 with 3 warning signs

No single metric tells the full story. See the NZSE:SCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scales Business Description

Other Exchanges S05:Germany
Address 52 Cashel Street, Christchurch, NZL, 8013
Scales Corp Ltd is a company engaged in agribusiness activities. It is principally engaged in the manufacture and trade of food ingredients, growing apples, operating processing facilities, exporting products, providing logistics services and providing insurance services to companies within the Group. The company's operating segments are Global Proteins, Horticulture, Logistics, and Others. The majority of the revenue for the company is generated from the Global Proteins segment, which is engaged in the processing and marketing of proteins such as pet food ingredients, edible meat, and offal products. Geographically, the company generates the maximum revenue from Asia and the rest from New Zealand, North America, Europe, and other regions.
99GF Score

Get the complete analysis for NZSE:SCL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$6.22
Price
NZ$6.68
GF Value